EP1954945A2 - Pulsatile rotary ventricular pump - Google Patents
Pulsatile rotary ventricular pumpInfo
- Publication number
- EP1954945A2 EP1954945A2 EP06838824A EP06838824A EP1954945A2 EP 1954945 A2 EP1954945 A2 EP 1954945A2 EP 06838824 A EP06838824 A EP 06838824A EP 06838824 A EP06838824 A EP 06838824A EP 1954945 A2 EP1954945 A2 EP 1954945A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- region
- taper
- conduit
- roller pump
- roller
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000541 pulsatile effect Effects 0.000 title claims abstract description 39
- 230000002861 ventricular Effects 0.000 title description 5
- 239000012530 fluid Substances 0.000 claims description 32
- 230000003205 diastolic effect Effects 0.000 claims description 4
- 238000001746 injection moulding Methods 0.000 claims description 4
- 238000005086 pumping Methods 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000009467 reduction Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 206010059484 Haemodilution Diseases 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000002631 hypothermal effect Effects 0.000 description 5
- 208000010496 Heart Arrest Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000002612 cardiopulmonary effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000003788 cerebral perfusion Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001595 flow curve Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/12—Machines, pumps, or pumping installations having flexible working members having peristaltic action
- F04B43/1215—Machines, pumps, or pumping installations having flexible working members having peristaltic action having no backing plate (deforming of the tube only by rollers)
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/0009—Special features
- F04B43/0054—Special features particularities of the flexible members
- F04B43/0072—Special features particularities of the flexible members of tubular flexible members
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B53/00—Component parts, details or accessories not provided for in, or of interest apart from, groups F04B1/00 - F04B23/00 or F04B39/00 - F04B47/00
Definitions
- the present invention relates to cardiovascular pumps, and more particularly, to cardiovascular roller pumps that create a pulsatile flow profile.
- Deep hypothermic circulatory arrest is commonly used in the repair of congenital defects of the heart. Cessation of blood flow to the collateral circulation allows the surgeon to properly visualize the surgical field, while hypothermia reduces metabolism providing cellular protection despite lack of oxygen delivery. In recent practice, deep hypothermic circulatory arrest is conducted with intermittent periods of very low blood flow in the range of 10 to 20 cc/kg/min or "trickle flow". It is commonly felt that this amount of flow can be provided without compromising the conduct of the surgical repairs, and will serve to preserve brain high energy phosphate concentrations and intracellular pH (20).
- the arterial pump In order to meet these requirements the arterial pump must be capable of maintaining flow accuracy over a broad range of flow rates and temperature from 10 cc/kg at 15 "C 1 to 150 cc/kg at 37 0 C. [0006] Centrifugal pumps are simply not practical in providing for extreme low flow rates due to excessive impeller speeds and resulting blood damage and in fact are relied on only in 2% of centers conducting pediatric heart surgery. Occlusive roller pumps are currently used; however, they are far from optimal in their use at low flow rates.
- roller pumps rely on a roller pressing against a piece of tubing backed by a rigid raceway. In order to fully occlude the circular tubing for use in very low flow conditions, excessive roller forces are needed to squeeze the tubing between the roller and raceway. This significantly increases stress and wear on the tubing, potentially causing leaks or ruptures.
- MAUDE Manufacturer and User Facility Device Experience Database
- a minimum "safety volume" of blood had to be maintained in the reservoir when using a roller pump so as to provide sufficient time for the perfusionist to react to sudden interruptions of venous return flow before the reservoir was drained. For example, at a flow rate of 1.5 l/min, using the known state-of-the-art Terumo Capiox reservoir, 300 ml of reservoir volume would provide less than 12 seconds of response time. [0009] This has prompted the use of reservoir level detectors and air detectors with pump shut off interconnections. 79.2% of centers conducting pediatric extracorporeal circulation (ECC) utilize reservoir level detectors, and 87.5% of these centers utilize air bubble detectors. However, despite their presence, these safety devices may fail to protect due to device failures and human errors.
- ECC extracorporeal circulation
- a typical circuit volume for a small infant could range from 600-800 ml.
- 200 additional ml are typically added to the circuit, which is usually whole blood or packed red blood cells. This safety volume is highly variable amongst practitioners and could be minimized if a self-limiting safety system was designed into the pump. If this 200 ml volume could be eliminated, the savings in both hemodilution side-effects and risks to additional blood product .transfusion would be of significant benefit.
- roller pump The purpose of the roller pump is to shuttle this fluid from the inlet to the outlet and force it to flow through the tubing circuit.
- this involves moving blood from a low pressure inlet to a high pressure outlet.
- a roller contacts and advances along the tubing filling it with low pressure blood.
- a second roller contacts the tubing and isolates the fluid between the rollers still at the low inlet pressure. This situation lasts only briefly as the first roller departs from the tubing exposing the low pressure isolated fluid to the high pressure outlet fluid. This causes an equilibration of pressure between the fluid volumes and is associated with a momentary drop in pressure in the outlet.
- the second roller continues to advance it drives the fluid forward reestablishing pressure within the outlet tubing.
- roller pump without a stator, utilizes a roller head
- roller pumps can be used to create pulsatile flow and pressure by rapidly accelerating the speed, revolutions per minute (RPM), of the rotor for a "systolic” period and reducing the speed (RPM) to create a "diastolic” period.
- RPM revolutions per minute
- This has significant disadvantages as it involves use of much greater power to accelerate the rotating mass, increases tubing wear, and increases blood exposure to damaging negative pressures. With this technique it is not possible to isolate the inlet conditions from the outlet conditions. Additionally, the inlet conditions vary as the speed (RPM) is modulated.
- the present invention provides a roller pump conduit, defining a pump chamber, that includes a roller contact portion having a fill region and a delivery region, the fill region having a first taper and being configured to determine volume delivery per revolution of a roller head.
- the delivery region has a pressure region having a second taper and a discharge region having a third taper.
- the second taper has a greater degree of taper than the third taper.
- the delivery region is configured to produce a pulsatile flow out of the conduit.
- a roller pump for pumping fluids is provided that comprises a plurality of rollers located in spaced apart relation. The rollers are attached to a rotor having a drive shaft.
- a flexible conduit is in mechanical communication with a plurality of rollers.
- the flexible conduit comprises a roller contact portion having a fill region and a delivery region, the fill region having a first taper.
- the fill region is configured to determine volume delivery per revolution of a roller head.
- the delivery region has a pressure region having a second taper and a discharge region having a third taper.
- the second taper has a greater degree of taper than the third taper.
- the delivery region is configured to produce a pulsatile flow out of the conduit.
- FIG. 1a is a side view of a roller pump conduit having a reduction in the cross sectional area within the delivery region of the conduit;
- FIG. 1b is a plan view of the roller pump conduit of FIG. 1a;
- FIG. 2 is a plan view of a roller pump having a flexible conduit as in
- FIGS. 1a and 1b are identical to FIGS. 1a and 1b;
- FIG. 3 is a graph of the outlet pressure of a roller pump having the conduit of FIGS. 1a and 1b, compared with the outlet pressure of a roller pump having a conduit without a reduction in the cross sectional area within the delivery region of the conduit;
- FIG. 4 is a graph of the flow rate of a roller pump having the conduit of
- FIGS. 1a and 1b compared with the outlet pressure of a roller pump having a conduit without a reduction in the cross sectional area within the delivery region of the conduit.
- a pulsatile rotary ventricular pump [0027] According to the present invention, a pulsatile rotary ventricular pump
- PRVP is provided as a significant advancement of pump technology, one also capable of addressing performance requirements unique to pediatric surgery.
- the innovative advances of the present invention in the chamber design create a pulsatile flow profile (see FIG. 4) that it is anticipated will assist in recovery from deep hypothermic cardiac arrest, a common surgical technique in pediatric patients.
- the present invention is capable of creating pressure and flow profiles that approximate the pressure and flow profiles created by a human heart.
- the chamber design and the specification of roller contact on the chamber will allow very fine control at low flows, which is critical in cerebral perfusion of neonates and which cannot be safely delivered by previous roller pumps.
- the PRVP will be significantly smaller than an adult pump. These and other features will close the gap between desired levels of performance and that provided by current pediatric arterial pumping technology, as noted in the table below.
- the invention detailed herein is a cost effective innovation for arterial pumping, particularly to pediatric heart surgery, including physiologic pulsatile flow, very low volume extracorporeal fluid management, ultra fine resolution low flow control, and inherent safety to protect against operator error.
- the pulsatile rotary ventricular pump (PRVP) of the present invention includes a flexible conduit 20 defining a pump chamber.
- the pump chamber includes specific regions, as shown in FIGS. 1a and 1b, which show the flexible conduit 20 in a side view and a plan view, respectively. These regions include the bias region L B , the low volume shut-off region L S o, the roller contact region L R , the fill region L F , the delivery region L D , the pressure region L P , and the discharge region LD C -
- Each region is designed to impart specific performance characteristics to the pump chamber. The exact dimensional parameters of each region can be adjusted to optimize the performance to the application.
- the bias region L B receives fluid into the flexible conduit from a venous reservoir and provides for low pressure head passive filling.
- the bias region L B includes the low volume shut-off region L S o. which stops the flow of fluid into the fill region LF when the shut-off region Lso is compressed.
- the shut-off region Lso provides low suction head shut-off for management of very low reservoir volumes.
- a roller contact region L R includes both the fill region L F and the delivery region L 0 . Each roller 24 contacts the fill region LF, and advances along the flexible conduit 20 through the fill region L F and into the delivery region L D .
- the fill region L F is connected to the bias region L B .
- the fill region L F determines volume delivery per revolution of pump head, or maximum flow rate. In other words, the fill region L F of the pump chamber determines the "stroke volume” or the amount of blood delivered per roller pass.
- the width, depth and wall thickness of the fill region L F are such that they optimize filling under low pressure head conditions.
- the fill region Lp has a taper, but that taper may have a magnitude or degree of taper equal to zero.
- the fill region Lp of FIGS. 1a and 1b has a constant width, and therefore, a taper of zero magnitude or degree.
- the delivery region L D includes a pressure region L P and a discharge region L D c-
- the pressure region L P is characterized by a tapering cross sectional area which results in pressurization of the advancing fluid.
- the tapering cross section of the pressure region Lp couples the larger-width fill region LF to the smaller- width discharge region LD C of the delivery region Lp.
- the discharge region LDC of the delivery region L 0 has a taper, but that taper may have a magnitude or degree of taper equal to zero.
- the discharge region L DC has a taper of lesser degree than the taper of the pressure region Lp.
- the discharge region L DC of FIGS. 1a and 1b has a constant width, and therefore, a taper of zero magnitude or degree.
- the amount of pressure developed is controlled by the total volume of the delivery region L D , as determined by the degree, or magnitude, and length of the taper of the pressure region Lp and the position of the taper of the pressure region Lp along the length of the flexible conduit
- the pressure region Lp provides augmented volume delivery for the
- portion of a roller pump 22 is provided.
- the flexible conduit 20 of FIGS. 1a and 1b is wrapped around a plurality of freely rotating rollers 24 mounted to a rotor 26, or roller head, of the roller pump 22.
- the rollers 24 are located in spaced apart relation.
- the flexible conduit 20 contacts at least two rollers 24 at a time when the roller pump 22 is in operation.
- the roller pump 22 of FIG. 1 has an enclosure 28, which serves as a protective shield around the moving rotor 26.
- the captured fluid remains isolated between the rollers 24. This causes the fluid to pressurize within the flexible conduit 20 between the rollers 24. Ideally the isolated fluid is brought to the same pressure or higher pressure than the fluid located in a portion of the flexible conduit 20 that is not isolated. [0038] In the delivery region L D , the roller 24 on the leading edge of the isolated fluid finally advances away from the flexible conduit 20, and the previously isolated fluid is exposed to the outlet 32. An initial pressurized discharge of fluid from the outlet 32 into the extracorporeal circuit (ECC) (not shown) occurs, followed by a reduced period of steady flow as the roller 24 passes over the discharge region l_ D c of the flexible conduit 20.
- ECC extracorporeal circuit
- EEP energy equivalent pressure
- the units for EEP are units of pressure, such as mmHg.
- EEP is always higher than the mean arterial pressure (MAP), whereas during non-pulsatile flow, EEP is very similar to the MAP.
- MAP mean arterial pressure
- Existing research has • shown that pulsatile flow generated higher hemodynamic energy compared with non-pulsatile flow.
- the human heart has been reported to have a 10% increase in EEP, whereas pulsatile roller pumps have previously had approximately a 4% increase in the EEP over the MAP.
- Non-pulsatile pumps only have an increase of about 1%.
- the PRVP according to the present invention can readily reach 10% and, higher increase in EEP.
- the pump chamber design of the flexible conduit 20 can be modified to increase the stroke volume of the roller pump 22. Parameters that can be varied include the width and thickness of the roller contact region L R and the width and thickness of the delivery region L D - If the pulse is too low, then the fill volume can be increased and/or the discharge volume can be decreased. If the pulse is too high, then a reduction in fill volume can be made or a change in the pressure region Lp taper can be made.
- FIGS. 3 and 4 respectively illustrate an outlet pressure/time graph and a flow rate/time graph. In both the outlet pressure graph (FIG. 3) and the flow rate graph (FIG.
- a prior art style pump chamber without a pressure build region L P and without a reduction in the degree of the taper within the delivery region L D , is designated as "Original”.
- the traces were recorded under identical operation conditions using a 4 inch diameter pediatric-sized rotor 26 having three rollers 24 and operating at an average outlet pressure of 50 mmHg, with an average flow rate of 1 liter/min, and water at room temperature as the pumped medium.
- the "Pulse” trace exhibits a pronounced increase in pulse pressure (FIG. 3) including rise time and amplitude, and a similarly steep rise in flow rate (FIG. 4) and pulsatile flow amplitude, when compared to the Original" trace.
- the present invention achieves pulsatile flow using a constant speed rotor 26, and, therefore, can implement pulsatile conditions at the outlet 32, all without affecting inlet conditions and without creating pulsatility at the inlet 30.
- This has advantages in avoiding low pressure at the inlet, keeping the speed of the rotor 26 low, avoiding excessive wear of the flexible conduit 20, and avoiding damage to the blood pumped through the flexible conduit 20.
- the flexible conduit 20 is made from polyurethane or another suitable flexible material.
- the flexible conduit 20 is manufactured by injection molding. By injection molding the pump chamber, a durable disposable flexible conduit 20 is produced that can be used for prolonged support after surgery, without the need for changing pumps.
- the foregoing disclosure is the best mode contemplated by the inventor for practicing this invention. It is apparent, however, that methods incorporating modifications and variations will be obvious to one skilled in the art. Inasmuch as the foregoing disclosure is intended to enable one skilled in the pertinent art to practice the instant invention, it should not be construed to be limited thereby but should be construed to include such aforementioned obvious variations and be limited only by the spirit and scope of the following claims.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Fertilizing (AREA)
- Reciprocating Pumps (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74152605P | 2005-12-01 | 2005-12-01 | |
PCT/US2006/046076 WO2007064927A2 (en) | 2005-12-01 | 2006-12-01 | Pulsatile rotary ventricular pump |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1954945A2 true EP1954945A2 (en) | 2008-08-13 |
EP1954945A4 EP1954945A4 (en) | 2008-12-10 |
EP1954945B1 EP1954945B1 (en) | 2010-04-14 |
Family
ID=38092845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06838824A Active EP1954945B1 (en) | 2005-12-01 | 2006-12-01 | Pulsatile rotary ventricular pump |
Country Status (6)
Country | Link |
---|---|
US (2) | US8162634B2 (en) |
EP (1) | EP1954945B1 (en) |
JP (1) | JP4621776B2 (en) |
AT (1) | ATE464479T1 (en) |
DE (1) | DE602006013692D1 (en) |
WO (1) | WO2007064927A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4621776B2 (en) * | 2005-12-01 | 2011-01-26 | ミシガン クリティカル ケア コンサルタンツ,インコーポレイテッド | Pulsating rotary ventricular pump |
US8226591B2 (en) | 2008-08-05 | 2012-07-24 | Michigan Critical Care Consultants, Inc. | Apparatus and method for monitoring and controlling extracorporeal blood flow relative to patient fluid status |
US10174751B2 (en) | 2009-07-14 | 2019-01-08 | Sanofi-Aventis Deutschland Gmbh | Pump chamber for a peristaltic pump |
US8074809B2 (en) * | 2009-07-17 | 2011-12-13 | Gordon H. King | Apparatus and method for the treatment of liquid/solid mixtures |
DE102009058279B4 (en) * | 2009-12-11 | 2016-05-12 | W. O. M. World of Medicine GmbH | Peristaltic peristaltic pump |
US8897523B2 (en) * | 2011-07-09 | 2014-11-25 | Gauss Surgical | System and method for counting surgical samples |
US10426356B2 (en) | 2011-07-09 | 2019-10-01 | Gauss Surgical, Inc. | Method for estimating a quantity of a blood component in a fluid receiver and corresponding error |
IN2014DN10002A (en) | 2012-05-14 | 2015-08-14 | Gauss Surgical | |
EP4033405B1 (en) | 2012-05-14 | 2024-06-12 | Gauss Surgical, Inc. | Methods for managing blood loss of a patient |
WO2016187070A1 (en) | 2015-05-15 | 2016-11-24 | Gauss Surgical, Inc. | Method for projecting blood loss of a patient during a surgery |
US11504037B2 (en) | 2015-05-15 | 2022-11-22 | Gauss Surgical, Inc. | Systems and methods for assessing fluids from a patient |
US10789710B2 (en) | 2015-05-15 | 2020-09-29 | Gauss Surgical, Inc. | Methods and systems for characterizing fluids from a patient |
EP3393539B1 (en) | 2015-12-23 | 2023-12-27 | Gauss Surgical, Inc. | System and method for estimating an amount of a blood component in a volume of fluid |
JP6934253B2 (en) | 2015-12-23 | 2021-09-15 | ガウス サージカル, インコーポレイテッドGauss Surgical, Inc. | How to assess the amount of blood components in a surgical fabric |
WO2018125812A1 (en) | 2017-01-02 | 2018-07-05 | Gauss Surgical, Inc. | Tracking surgical items with prediction of duplicate imaging of items |
US11229368B2 (en) | 2017-01-13 | 2022-01-25 | Gauss Surgical, Inc. | Fluid loss estimation based on weight of medical items |
DE102019004825A1 (en) * | 2019-07-10 | 2021-01-14 | Xenios Ag | Control for non-occlusive blood pumps |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2123781A (en) | 1936-06-16 | 1938-07-12 | Charles J Huber | Pump |
US3295556A (en) | 1963-08-26 | 1967-01-03 | Laurence W Gertsma | Foldable conduit |
US3403631A (en) | 1967-03-28 | 1968-10-01 | Dempster Ind Inc | Flow metering and dividing device |
US3756752A (en) | 1971-12-20 | 1973-09-04 | G Stenner | Peristaltic pump |
GB1539371A (en) | 1975-01-17 | 1979-01-31 | Clarke E | Means for controlling fluid flow |
DE2530149A1 (en) * | 1975-07-05 | 1977-02-03 | Wilhelm Dipl Ing Ritter | PERISTALTIC PUMP |
FR2317526A1 (en) | 1975-07-08 | 1977-02-04 | Rhone Poulenc Ind | PERISTALTIC PUMP |
DE2535650C2 (en) | 1975-08-09 | 1982-05-27 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG Apparatebau KG, 6380 Bad Homburg | Roller peristaltic pump with an electric drive motor |
GB1501273A (en) | 1975-08-22 | 1978-02-15 | Avon Medicals | Producing a flow restrictor |
US4211519A (en) | 1977-08-29 | 1980-07-08 | Cole-Parmer Instrument Company | Fluid pump and quick release mounting arrangement therefor |
AT359768B (en) | 1979-01-08 | 1980-11-25 | Waldhauser Maschf | CONTROL HOSE |
US4686085A (en) | 1980-04-14 | 1987-08-11 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4445886A (en) | 1980-04-14 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4445500A (en) | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4478661A (en) | 1981-03-20 | 1984-10-23 | Dayco Corporation | Method of making a reinforced collapsible hose construction |
US4515589A (en) | 1981-03-23 | 1985-05-07 | Austin Jon W | Peristaltic pumping method and apparatus |
GB2107796B (en) | 1981-10-07 | 1985-02-27 | Autoclude Ltd | Peristaltic pumping device |
AU565652B2 (en) | 1982-02-19 | 1987-09-24 | Dow Chemical Company, The | Hollow fibre oxygenator element |
AU1139583A (en) | 1982-02-25 | 1983-09-01 | John T. Broadfoot | Peristaltic pump |
DE3320091A1 (en) | 1983-06-03 | 1984-12-06 | Streicher, Irmgard, 7141 Beilstein | HOSE PUMP |
US4515535A (en) | 1983-08-15 | 1985-05-07 | Baxter Travenol Laboratories, Inc. | Peristaltic pump quick disconnect rotor assembly |
US4650471A (en) | 1984-01-20 | 1987-03-17 | Yehuda Tamari | Flow regulating device for peristalitic pumps |
US4734184A (en) | 1985-08-29 | 1988-03-29 | Diamond Sensor Systems, Inc. | Self-activating hydratable solid-state electrode apparatus |
US4786394A (en) | 1985-08-29 | 1988-11-22 | Diamond Sensor Systems, Inc. | Apparatus for chemical measurement of blood characteristics |
US4631008A (en) | 1985-11-04 | 1986-12-23 | G. H. Stenner & Co., Inc. | Peristaltic pump housing |
DE3616062A1 (en) | 1986-05-13 | 1987-11-19 | Fresenius Ag | METHOD FOR DETERMINING GAS PARTIAL PRESSURES IN BLOOD AND DEVICE FOR IMPLEMENTING THE METHOD |
US4767289A (en) | 1986-12-31 | 1988-08-30 | Minnesota Mining And Manufacturing Company | Peristaltic pump header |
US4871439A (en) | 1987-02-05 | 1989-10-03 | Steven Enzer | Disposable self-calibratable electrode package |
US5141504A (en) | 1987-03-02 | 1992-08-25 | Atrium Medical Corporation | Fluid recovery system with stopcock suction control |
US5195960A (en) | 1987-04-27 | 1993-03-23 | Site Microsurgical Systems, Inc. | Disposable vacuum/peristaltic pump cassette system |
US5215501A (en) | 1988-03-24 | 1993-06-01 | Ngk Insulators, Ltd. | Hysteresis magnet coupling for roots type pumps |
US5139741A (en) | 1988-12-29 | 1992-08-18 | Terumo Kabushiki Kaisha | Blood processing apparatus of hollow fiber type |
DE3909657A1 (en) | 1989-03-23 | 1990-09-27 | Braun Melsungen Ag | PUMP HOSE FOR A PERISTALTIC PUMP |
US4954055A (en) * | 1989-06-22 | 1990-09-04 | Baxter International, Inc. | Variable roller pump tubing |
US5215450A (en) | 1991-03-14 | 1993-06-01 | Yehuda Tamari | Innovative pumping system for peristaltic pumps |
US5614378A (en) | 1990-06-28 | 1997-03-25 | The Regents Of The University Of Michigan | Photobioreactors and closed ecological life support systems and artifificial lungs containing the same |
US5380314A (en) | 1991-09-04 | 1995-01-10 | Atrium Medical Corporation | In-line fluid recovery system |
US5067879A (en) | 1990-09-18 | 1991-11-26 | Carpenter Walter L | Peristaltic pump system |
US5222880A (en) * | 1991-10-11 | 1993-06-29 | The Regents Of The University Of Michigan | Self-regulating blood pump |
US5282783A (en) | 1991-12-17 | 1994-02-01 | Minnesota Mining And Manufacturing Company | Blood reservoir |
US5281112A (en) | 1992-02-25 | 1994-01-25 | The Regents Of The University Of Michigan | Self regulating blood pump with controlled suction |
US5391142A (en) | 1992-07-29 | 1995-02-21 | Organetics, Ltd. | Apparatus and method for the extracorporeal treatment of the blood of a patient having a medical condition |
EP0583003A1 (en) | 1992-08-13 | 1994-02-16 | Perseptive Biosystems, Inc. | Fluid metering, mixing and composition control system |
JP3315224B2 (en) | 1993-12-09 | 2002-08-19 | 千寿製薬株式会社 | Micro flow pump |
CA2165166C (en) | 1994-04-15 | 2002-12-17 | John J. Pacella | Blood pump device and method of producing |
US5512042A (en) | 1994-05-20 | 1996-04-30 | Michigan Critical Care Consultants, Inc. | Venous blood reservoir with increased level and volume sensitivity |
DE4430853A1 (en) | 1994-08-31 | 1996-03-07 | Jostra Medizintechnik | Centrifugal blood pump |
US5486099A (en) | 1994-12-14 | 1996-01-23 | Michigan Critical Care Consultants, Inc. | Peristaltic pump with occlusive inlet |
US6047108A (en) | 1996-10-01 | 2000-04-04 | Baxter International Inc. | Blood warming apparatus |
US6129699A (en) | 1997-10-31 | 2000-10-10 | Sorenson Development, Inc. | Portable persistaltic pump for peritoneal dialysis |
US6962488B2 (en) | 1999-11-10 | 2005-11-08 | Alcon, Inc. | Surgical cassette having an aspiration pressure sensor |
AU2002951685A0 (en) | 2002-09-30 | 2002-10-17 | Ventrassist Pty Ltd | Physiological demand responsive control system |
CN100344874C (en) | 2003-01-28 | 2007-10-24 | 清华大学 | Fluid transmission method and minisize peristaltic pump for realizing the same |
ITMO20030293A1 (en) | 2003-10-29 | 2005-04-30 | Gambro Lundia Ab | DEVICE FOR THE DETERMINATION OF THE BLOOD FLOW IN AN EXTRACORPOREO CIRCUIT, AS WELL AS THE EQUIPMENT FOR BLOOD TREATMENT USING THE SAME DEVICE. |
JP4621776B2 (en) | 2005-12-01 | 2011-01-26 | ミシガン クリティカル ケア コンサルタンツ,インコーポレイテッド | Pulsating rotary ventricular pump |
JP5201887B2 (en) | 2007-06-20 | 2013-06-05 | テルモ株式会社 | Blood pump system for artificial heart and device monitoring system |
US8226591B2 (en) | 2008-08-05 | 2012-07-24 | Michigan Critical Care Consultants, Inc. | Apparatus and method for monitoring and controlling extracorporeal blood flow relative to patient fluid status |
-
2006
- 2006-12-01 JP JP2008543504A patent/JP4621776B2/en not_active Expired - Fee Related
- 2006-12-01 DE DE602006013692T patent/DE602006013692D1/en active Active
- 2006-12-01 US US12/095,733 patent/US8162634B2/en active Active
- 2006-12-01 EP EP06838824A patent/EP1954945B1/en active Active
- 2006-12-01 AT AT06838824T patent/ATE464479T1/en not_active IP Right Cessation
- 2006-12-01 WO PCT/US2006/046076 patent/WO2007064927A2/en active Application Filing
-
2012
- 2012-04-17 US US13/449,234 patent/US8678792B2/en active Active
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO2007064927A2 * |
Also Published As
Publication number | Publication date |
---|---|
US8162634B2 (en) | 2012-04-24 |
EP1954945A4 (en) | 2008-12-10 |
US8678792B2 (en) | 2014-03-25 |
ATE464479T1 (en) | 2010-04-15 |
WO2007064927A3 (en) | 2008-06-19 |
JP4621776B2 (en) | 2011-01-26 |
JP2009518070A (en) | 2009-05-07 |
US20130101452A1 (en) | 2013-04-25 |
WO2007064927A2 (en) | 2007-06-07 |
EP1954945B1 (en) | 2010-04-14 |
US20100150759A1 (en) | 2010-06-17 |
DE602006013692D1 (en) | 2010-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8162634B2 (en) | Pulsatile rotary ventricular pump | |
US10245363B1 (en) | Catheter-based pump for improving organ function | |
US7766892B2 (en) | Apparatus and methods for treating congestive heart disease | |
CA2926718C (en) | Device and method for regulating and presetting the pump rate of blood pumps | |
US20190167878A1 (en) | Catheter-based pump for improving organ function | |
US8603021B2 (en) | Method and apparatus for ultrafiltration of blood | |
US7335192B2 (en) | Apparatus and methods for treating congestive heart disease | |
US6406267B1 (en) | Extracorporeal circulation pump | |
US20170112984A1 (en) | Chamber for artificial circulatory assistance and membrane | |
US20240285930A1 (en) | Fluid circulation chamber membrane, a chamber and pump for artificial circulatory assistance and a pumping system | |
US8317499B2 (en) | Pulsatile peristaltic pump for use in a cardiopulmonary bypass | |
Toomasian et al. | Extracorporeal circulation for port-access cardiac surgery | |
Darling et al. | Modified ultrafiltration in pediatric cardiopulmonary bypass | |
US12029889B2 (en) | Perfusion systems and methods for monitoring tissue oxygenation and reducing limb ischemia | |
US20240350793A1 (en) | Perfusion systems and methods for monitoring tissue oxygenation and reducing limb ischemia | |
Brancaccio et al. | A circuit to perform a combined ultrafiltration procedure in pediatric open heart surgery | |
Kraemer | Single-needle dialysis | |
Kijima et al. | The margin of safety in the use of a straight path centrifugal blood pump | |
CA2312298A1 (en) | Extracorporeal circulation pump | |
Deptula et al. | Modified ultrafiltration postextracorporeal membrane oxygenation | |
GIL-RODRIGUEZ | Emergency extracorporeal circulation | |
EXTRACORPOREAL | PHYSIOLOGY OF EXTRACORPOREAL MEMBRANE OXYGENATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080612 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20081110 |
|
17Q | First examination report despatched |
Effective date: 20090324 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 602006013692 Country of ref document: DE Date of ref document: 20100527 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20100414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100725 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100814 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100602 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100816 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100715 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 |
|
26N | No opposition filed |
Effective date: 20110117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101015 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100714 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20191129 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20201208 Year of fee payment: 15 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20201201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201201 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20211115 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20211215 Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20211202 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20230101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221201 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231108 Year of fee payment: 18 Ref country code: DE Payment date: 20231108 Year of fee payment: 18 |